Welcome to EG&S
Our Firm is designed to address the specific legal requirements of our clients. Descriptions of our core practice groups are accessible below:
News & Events
Barry Grossman gave a presentation on the requirements and methodologies used to Go Private and participated on a panel discussing...
January 11, 2012Ellenoff Grossman & Schole LLP was ranked #4 for issuer representation in IPO transactions (by number of transactions)...
January 4, 2012Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions)...
December 30, 2011AspenBio Pharma, Inc. announced the closing of their registered direct offering in the amount of $1,637,100. EG&S acted as counsel to...
December 28, 2011Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100. EG&S acted as...
December 28, 2011Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000. EG&S acted as counsel to...
December 27, 2011Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement...
December 21, 2011StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the...
December 13, 2011PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company, announced the completion of their...
December 13, 2011Cell Therapeutics Inc. announced the closing of their registered direct in the amount of $20,000,000. EG&S acted as counsel to the...
Resource Center
Ellenoff Grossman & Schole LLP has established several resource centers where we've compiled current relevant articles on specific topics that have appeared in various newspapers, magazines and online journals

